The global rheumatology therapeutic market is anticipated to rise at a significant CAGR in the forthcoming period. Rheumatic diseases are inflammatory and are better known as rheumatoid arthritis or systemic lupus erythematosus (SLE). Being severe and chronic by nature, these diseases affect every age group and may cause deterioration of quality of life and pose a major health care burden across the globe. Ongoing developments for novel therapies which are efficient and cost-effective in terms of diagnosis. For instance, steroids and non-steroidal anti-inflammatory drugs are introduced into therapy of inflammatory rheumatic diseases.
At present, therapeutic drug monitoring and pharmacogenomics are two techniques to diagnose rheumatic diseases. From the commercial standpoint, pharmacogenetic tests have made up to rheumatic diseases. Driving factors responsible for the growth of rheumatology therapeutic industry includes rise in geriatric population and rise in disposable income coupled with adoption of biosimilars.
Segmentation based on drug class for rheumatology therapeutic market includes disease modifying anti-rheumatic drugs, nonsteroidal anti-inflammatory drugs, corticosteroids, uric acid. Segmentation based on disease indication for the market includes rheumatoid arthritis, osteoarthritis, psoriatic arthritis, gout and ankylosing spondylitis. Segmentation based on distribution channel for rheumatology therapeutic industry includes hospital, online pharmacy and retail pharmacy.
Geographical segmentation for rheumatology therapeutic market spans North America, South America, Europe, Asia-Pacific, Middle-East and Africa. North America market is expected to dominate the market growth owing to rise in geriatric population suffering from rheumatology disorders. In addition, inclination towards biosimilar and biologics products to diagnose moderate and severe rheumatoid arthritis coupled with specialty centers and healthcare facilities is expected to boost the growth of rheumatology therapeutic industry in the forthcoming period.
Europe and APAC market is expected to gain a significant share in the rheumatology therapeutic industry due to rise in geriatric population and establishment of healthcare facilities. Other factors such as rise in per capita healthcare expenditure and adoption of biosimilars to diagnose rheumatology disorders. The key players in rheumatology therapeutic market include Abbott, Pfizer, Amgen, Janssen Biotech, Merck and Co Inc, Squibb Company, Bristol-Myers, Novartis AG, Biotech Inc, Genentech Inc and Takeda Pharmaceutical.
This report studies the global Rheumatology Therapeutic market, analyzes and researches the Rheumatology Therapeutic development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
• Pfizer, Inc.
• Bristol-Myers Squibb Company
• AbbVie, Inc.
• Merck & Co.Inc.
• Genentech, Inc.
• Amgen, Inc.
• Takeda Pharmaceutical
• Novartis AG
Market segment by Regions/Countries, this report covers
• United States
• Southeast Asia
Market segment by Type, the product can be split into
• Rheumatoid Arthritis
• Psoriatic Arthritis
• Ankylosing Spondylitis
Market segment by Application, Rheumatology Therapeutic can be split into
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Research Support Specialist, USA